In situ, reversible coacervate formation within lipid vesicles represents a key step in the development of responsive synthetic cellular models. Here we exploit the pH responsiveness of a polycation above and below its pKa, to drive liquid-liquid phase separation, to form single coacervate droplets within lipid vesicles. The process is completely reversible as coacervate droplets can be disassembled by increasing the pH above the pKa. We further show that pH triggered coacervation in the presence of low concentrations of enzymes activate dormant enzyme reactions by molecular upconcentration into the coacervate droplets. In conclusion, this work establishes a tuneable, pH responsive, enzymatically active multicompartment synthetic cell. The system is readily transferred into microfluidics, making it a robust model for addressing general questions in biology such as the role of phase separation and its effect on enzymatic reactions using a bottom-up synthetic biology approach. This article is protected by copyright. All rights reserved. Microscopy Facility and the Scientific Computing Facility at the MPI-CBG for assistance; Christoph Zechner for discussions regarding data analysis; Juan M. Inglesias-Artola and Björn Drobot for assistance with the FRAP analysis code; and Anatol W. Fritsch for assistance with undertaking spinning disk confocal microscopy experiments with the Olympus IXplore IX83 microscope.
Introduction
Hybrid protocells with structural features of both membranebound and membrane-free compartmentalisation which respond to external stimuli, offer a blueprint for the genesis of dynamic synthetic cellular models. These provide distinct, unique and dynamic environments for the spatial organisation of reactions.
Membrane-free coacervate microdroplets form via liquid-liquid phase separation between oppositely charged polypeptides, polynucleotides, polymers and macromolecules. This coacervation process has attracted a lot of attention as it has recently been demonstrated to be one of the driving forces of cellular condensate formation [1] , [2] , [3] , [4] . Cytoplasmic phase demixing [1] , [2] and synthetic liquid droplets [3] , [4] , [5] have been shown to respond reversibly to changes in pH, salt, enzymes and light in vivo and in vitro. Here, regulation of the molecular charge or chemical structure of the coacervate forming components leads to the mixing and de-mixing of the microdroplet resulting in dramatic changes in the local environment.
In addition, hybrid protocells of membrane-free subcompartments within either water-in-oil (w/o) emulsions, giant vesicles [6] or proteinosomes have been formed by spontaneous self-assembly methods in bulk or by using microfluidic methodologies [7] , [8] , [9] . In these systems, changes in temperature or osmotic pressure from the exterior of the lipid vesicles have led to phase separation of aqueous two phase systems [10] , [11] and coacervates [12] within the lipid vesicle. However, to the best of our knowledge there have been no examples of in situ formation of enzymatically active coacervates within lipid vesicles by an external pH stimulus.
To this end, we have developed a methodology for the in situ, pH reversible formation of coacervate microdroplets within giant unilamellar vesicles (GUVs). The membrane bounded lipid vesicle supports the isolation of the coacervate components from its exterior whilst permitting the transfer of water and protons across the lipid membrane [13] . By exploiting the pH responsiveness of polylysine (PLys), a coacervate forming polypeptide [3] , [14] , we demonstrate that coacervate formation can be initiated within the lipid vesicle via an external change in pH.
Above the pKa of PLys, coacervate formation with a counter polyanion is arrested and below the pKa of PLys, coacervate formation is triggered. We further show that this methodology is compatible with the encapsulation of enzymatic reactions and that in situ coacervate formation leads to the activation of enzymatic reactions by the up-concentration within a coacervate droplet. Our modular approach is robust, reproducible and can also be transferred to microfluidic methodologies, further demonstrating the verstatility of the method.
It is not completely understood why membrane-free compartmentalisation is important in biological systems. It has been postulated that these dynamical liquid-liquid phase separation processes can play a role in regulating biochemical processes [15] , [16] , [17] , [18] . However, investigating these processes within the complex environment of the cell is challenging. Our work therefore offers key steps in the synthesis of dynamic protocellular systems in bottom-up synthetic biology and can be used to help test current models of the role of liquid-liquid phase RESEARCH ARTICLE separation in biology. Overall, this study presents a minimal model system for probing general phenomena in modern biology,
where it is known that pH changes can lead to alterations of the material properties of liquid-liquid phase separated droplets and affect biochemical enzymatic reactions inside cells. for PLys-FITC. The raw data (shaded grey), mean (dark blue) and 95% confidence limit (light blue) from 16 experiments are shown. The recovery profile was fit to a double exponential curve to obtain the diffusion coefficients 2.4 ± 1.4 µm 2 s -1 and 0.4 ± 0.17 µm 2 s -1 .
Results and Discussion
Reversible formation of coacervates within lipid vesicles can be regulated by tuning pH. To encapsulate coacervate forming components, GUVs were formed using the gel-assisted swelling methodology [19] in the presence of polylysine (PLys) with either CM-Dextran or Adenosine Triphosphate (ATP) (Fig. 1A, Fig. S1 ).
Coacervation was inhibited during vesicle formation by setting the pH above the pKa of PLys (pH 10.5) ( Fig. 1B) Fig. S2) . The vesicles were typically between 2-30
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µm in diameter, which is expected of GUVs produced via the gelassisted swelling method. To ensure that coacervate microdroplets would only form within the vesicles, the GUV dispersions were washed with an iso-osmolar glucose solution at pH 11 to remove excess coacervate components from the outside of the vesicles (see materials and methods). Confocal microscopy images showed that the vesicles had been successfully washed as fluoresence intensity line profiles across the lipid vesicle, normalised to 1, showed a low level of fluorescence intensity on the outside of the lipid vesicles compared to before the wash step ( Fig. 1Ci,ii and Fig. S2 ).
Next, we aimed to induce coacervation within the GUVs by lowering the pH below the pKa of PLys. The pH of the system was reduced to 9-8.5 by adding an iso-osmolar glucose buffer at pH 7.3. The final pH was confirmed by undertaking control experiments without GUVs where the same volume of pH 7 buffer was exchanged for pH 11 buffer and the pH measured. Confocal fluorescence images following the pH reduction showed initial formation of a number of small droplets inside the lipid vesicles with high FITC fluorescence intensity attributed to accumulation of FITC-tagged PLys (Fig. S3 ). These droplets fused together over time to produce a single highly fluorescent microdroplet within each individual lipid vesicle ( Fig. S3, and Fig. 1Di ,ii). This process of nucleation and growth is characteristic of coacervate formation within lipid vesicles or within water-oil emulsions [7] , [8] and occurred on the order of tens of minutes ( Fig. S3 ). It is interesting to note that line profiles show no fluorescence intensity from the lipid dye, DiD, within the PLys-rich droplets and no FITC fluorescence within the lipid membrane ( Fig. 1Di ,ii). This shows that the coacervate microdroplet is a distinct and separate subcompartment within the lipid vesicle as there is no crosscontamination of the lipid within the coacervates. After formation, the PLys rich droplets and lipid vesicles remain stable for at least one day (Fig. S4 ).
We next aimed to test whether coacervation within GUVs is reversible by increasing the pH to above the pKa of pLys. At this pH the amine group is deprotonated and electrostatic interactions between the coacervate components are annulled (Fig. 1A) . To do this, we increased the pH by exchanging the outer vesicular solution for an iso-osmolar glucose buffer at pH 11 and observed that the coacervation process within the GUVs is completely reversible. Confocal fluorescence images showed a transition of the FITC fluorescence from a heterogeneous coacervate droplet, to a homogeneous distribution throughout the interior of the GUVs upon increasing the pH of the dispersion to pH 11 as observed prior to the first pH switch (Fig. 1Ei,ii and Fig. S5 ).
To confirm that PLys rich droplets, at pH 9, were indeed fluid coacervate microdroplets, fluorescence recovery after photobleaching (FRAP) of FITC-tagged PLys within the microdroplets in the hybrid protocells was undertaken (Fig. 1F,   Fig. S6 ). FRAP data was normalised for bleaching and the whole coacervate droplet showed a 100 % fluorescence recovery which is characteristic of the microdroplets and attributed to the liquidlike and dynamic behaviour of coacervates [20] , [21] . In addition, fitting the recovery profile to a double exponential gave two time constants, t, of 0.19 ± 0.12 s and 3.07 ± 6.6 s and diffusion are indeed characteristic coacervate droplets [20] , [21] , [22] .
To further validate that coacervation was taking place between the PLys and its counter charged electrolyte as described, we undertook the same encapsulation and pH switch methodology but with PLys alone (in the absence of ATP) within the lipid vesicle. At pH 11 the PLys was diffuse and evenly distributed throughout the GUV. Upon acidification to pH 9, there was no change in the distribution of dye (Fig. S7 ). This data confirmed that the liquid droplets formed via electrostatic interactions and subsequent phase separation between PLys and its counter molecule (ATP).
Taken together, these results demonstrate that our methodology can be used to reversibly tune the formation and dissolution of a single PLys/ATP coacervate microdroplet within a GUV. The fact that these hybrid protocells are stable for at least a day suggests that these platforms can also be used to support enzymatic reactions.
Dynamic compartmentalisation facilitates enzymatic activity.
To determine whether in situ dynamic compartmentalisation could support and tune enzymatic reactions, we examined the activity of formate dehydrogenase in our system.
In this well-established assay, formate dehydrogenase oxidises formate to carbon dioxide, with the concatenate reduction of NAD+ to fluorescent NADH. It has previously been shown that coacervate microdroplets will 10 .1002/anie.201914893
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Angewandte Chemie International Edition partition and up-concentrate a range of substrates and molecules [23] , [24] . Therefore, we wondered whether inducing coacervation could alter enzymatic reactions via the up concentration of enzyme reactants within the coacervate droplet as previously observed with aqueous two phase systems [25] ( Fig.   2A ).
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Firstly, we probed the effect of in situ compartmentalisation on the enzyme formate dehydrogenase. FITC-labelled formate dehydrogenase (0.1 U mL -1 ) was co-encapsulated within POPC:
cholesterol vesicles and the coacervate components at pH 11, as within the GUV and the coacervate microdroplet ( Fig. 2Bi,ii) . Our results, along with control experiments (Fig. S9) , confirm that formate dehydrogenase is active at pH 9 and after a pH switch.
Building on our results, we wanted to exploit in situ coacervation as a means to activate the formate dehydrogenase reaction by the up-concentration of the reactants into the coacervate droplet ( Fig. 2A) . Control experiments had shown that NADH production within lipid vesicles, in the absence of coacervate forming components, was dependent on the concentration of formate dehydrogenase. End-point
measurements showed that at low concentrations of formate dehydrogenase (0.005 U mL -1 ) there was no NADH production, after 24 hrs, compared to increased concentrations of formate dehydrogenase (0.1, 0.05 U mL -1 ) (Fig. S10 ). We therefore encapsulated formate dehydrogenase (0.005 U mL -1 ) with formate (5 mM) and β-NAD + (0.45 mM) into POPC/cholesterol vesicles with and without PLys and ATP, at pH 11 to determine whether up-concentration of formate dehydrogenase into the coacervate droplet would switch on the production of NADH.
Following our established methodology, the two populations of vesicles were washed and coacervation was triggered by a reduction in pH to pH 9. After 24 hours, vesicles with and without coacervates were characterised for NADH production. Confocal fluorescence microscopy images showed high fluorescence intensity associated with NADH within the coacervate droplet encapsulated within the vesicle but no NADH fluorescence within the vesicles without coacervate microdroplets ( Fig. 2C,D) . The Taken together, our analysis shows our methodology is reproducible and applicable to different coacervate systems provided one of the two components has a pH dependent moiety.
In addition, the size of the coacervate droplet is directly influenced by the size of the encapsulating vesicle. Despite the clear reproducibility of the methodology, we sought to improve upon the size distribution of the vesicle and corresponding coacervate droplets by using microfluidic techniques.
Microfluidic production of hybrid protocells. Microfluidic methodologies would enable us to produce monodisperse vesicles encapsulating coacervates with higher reproducibility and lower variance in size in a high throughput manner.
Additionally, a microfluidic approach uses distinct solutions inside and outside the GUVs during formation, which then removes subsequent wash steps required in our bulk methodology. We used double-emulsion based microfluidics to generate lipid vesicles which contain dissolved coacervate components at pH 11. The device was made from PDMS using standard soft lithography methods and had a double cross junction geometry [26] (see materials and methods) (Fig. 4Ai,ii) with channel heights of 50 µm. Fig. 4Bi) . Coacervation was triggered with the addition of iso-osmotic pH 7.3 glucose buffer (Fig 4Bii) . Coacervates formed over a 15 h period (Fig. S17) .
Using this device, we achieved a 100 % encapsulation efficiency ( Fig. S18 ), which has not been possible using other microfluidic approaches [7] . The lipid vesicles produced were larger and more homogeneous in size compared to the swelling methodology 
Conclusion
In conclusion, we have presented a robust and reproducible methodology for the tuneable formation of liquid-liquid phase separated droplets within giant unilamellar vesicles. By exploiting the intrinsic pKa of cationic PLys we have generated a responsive system where phase separation is triggered though an external reduction in pH. We have further shown that we can utilise the Abstract: In situ, reversible coacervate formation within lipid vesicles represents a key step in the development of responsive synthetic cellular models. Here we exploit the pH responsiveness of a polycation above and below its pKa, to drive liquid-liquid phase separation to form single coacervate droplets within lipid vesicles. The process is completely reversible as coacervate droplets can be disassembled by increasing the pH above the pKa. We further show that pH triggered coacervation in the presence of low concentrations of enzymes activate dormant enzyme reactions by molecular up-concentration into the coacervate droplets. In conclusion, this work establishes a tuneable, pH responsive, enzymatically active multi-compartment synthetic cell. The system is readily transferred into microfluidics, making it a robust model for addressing general questions in biology such as the role of phase separation and its effect on enzymatic reactions using a bottom-up synthetic biology approach. , FDH (10 un mL -1 ), β-NAD + (45 mM), sodium formate (0.5 or 1 M) and HEPES (5 mM, pH 7.3). The pH of all stocks was adjusted using a 10 M NaOH solution. Aqueous stock solutions including buffer were stored at -20 o C until use. Stock solutions of lipids POPC, Cholesterol and the dye DiD) were prepared in chloroform to a concentration of 4 mM and stored under argon at -20 o C until use. Glass slides were pegylated by leaving the slides in a stirred bath of toluene with PEGsilane (0.2 %), activated with concentrated HCL (0.08 %) overnight at room temperature. Slides were then washed with toluene, ethanol and then water and dried with compressed air.
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Inner and outer solutions for swelling of giant unilamellar vesicles (GUVs)
Typical inner liposome solutions consisted of 3.5 -5 mM HEPES, 180 -200mM Sucrose and either PLys (40 mM), PLys (40 mM) and ATP (10 mM) or CM-Dextran (40 mM) and PLys (10 mM) with FITC tagged PLys (0.25% v/v). For experiments with the enzyme formate dehydrogenase (Fig. 5 ), reactants were added to the inner solution to final concentrations of either 0.1 or 0.005 un mL -1 (FDH), 4 mM (sodium formate) and 0.45 μM (β-NAD + ). All inner solutions were prepared at pH 11 by addition of 10 mM NaOH. Final osmolarities ranged between 200 to 240 mOsmol kg -1 . The osmolarity of the solution was measured with a cryoscopic osmometer, Osmomat 030 (Gonotec, Berlin, Germany) by freezing point depression.
Typical outer solutions consisted of HEPES (2-5 mM) and glucose (200 -240 mM) adjusted to either pH 11 (wash solution) or pH 7.3 (trigger solution) with 10 M NaOH solution. The osmolarity was adjusted using either a 2.5 M glucose solution or water, to be within + 5 mOsmol kg -1 of the inner solution.
Preparation of GUVs with encapsulated coacervate polymers
Giant vesicles were prepared by hydration of a lipid film dried onto a PVA film as described previously with minor modifications 1 . Glass microscope slides were cleaned with ethanol and water and then dried thoroughly with air. 50 μL of a 4% (w/v) PVA solution in Mili-Q water was then spread onto three-quarters of a glass microscope slide using a pipette tip and then incubated on a hot plate at 40 • C for 20 mins to dry the PVA. The temperature of the hot plate was then increased to 55 • C for another 10 minutes to ensure that the PVA film was completely dry. 2.5 μL of a 4 mM lipid/chloroform solution containing POPC:Cholesterol:DiD at a molar ratio of 90: 9.7: 0.3 respectively, was then distributed onto the PVA film using a glass Hamiltonian syringe by gently running it over the surface of the PVA. The slide was then left under vacuum for at least 1 hour to remove all of the chloroform.
A chamber was assembled around the dried lipid and PVA film by placing a 1 mm thick Teflon spacer on top of the PVA, then placing glass cover slip on top of the spacer and securing these with bulldog clips. The chamber was filled with approximately 600 µL of the inner sucrose solution with the coacervate polymers and then left in the dark at room temperature for 30 mins, to allow hydration and swelling of the lipid film and the formation of lipid vesicles. GUVs were then harvested by gently tapping the bottom of the chamber, then careful pipetting the solution from the chamber into an Eppendorf tube. Typically, samples were used within 24 hours, but were stable at 4 o C for up to a month.
Reversible in situ formation of coacervates within lipid vesicles triggered by pH
100 μL of the lipid vesicles solution was loaded into a chamber formed from an 8 well bottomless µ-Slide with a self-adhesive underside (Ibidi GmbH, Germany) attached to a PEGylated 24 x 60 mm glass cover slips. An additional 500 μL of the wash solution (pH 11) was added to the GUV dispersion and gently pipetted to mix and then left for 15 mins to allow the lipid vesicles to settle to the bottom of the chamber. An additional 300 µL of wash solution was added and left to equilibrate for 5 mins. The vesicles were then washed by exchanging the chamber solution with 200 µL of the outer wash solution, at least 6 times, to remove excess coacervate polymers and reactants for the enzyme assay from the outer solution.
To trigger coacervation within the lipid vesicles, the same volume (typically 200 µL) of wash solution (pH 11) was exchanged for the trigger solution (pH 7.3), exchange of the buffer was repeated at least twice (400 µL) and up to four times (800 µL). To initiate coacervate dissolution, the chamber solution was exchanged for the wash solution (pH 11) in the same way as coacervation formation.
Preparation of FITC tagged enzymes
Proteins were labelled with Fluorescein isothiocyanate (FITC) (10 mM in ethanol) using standard protocols. 10 mg of formate dehydrogenase was dissolved in 0.1 M sodium carbonate buffer (pH 9) at a concentration of 2 mg ml -1 . Whilst stirring the protein solution, FITC was added stepwise in 5 µL aliquots to a final volume of 20 µL for every 1 ml of protein solution. The solution was dialyzed for 2 hours in 5 mL of Milli-Q water, and then overnight in another 2 mL of Milli-Q to remove any excess FITC. The tagged dye was stored in aqueous solution at -20 o C until use.
Activity of formate dehydrogenase bulk coacervate dispersions
Enzyme activity was confirmed by observing formate dehydrogenase kinetics in dispersions of coacervate microdroplets. The enzyme reaction was prepared in 20 µL of HEPES/Sucrose (5 mM/ 200 mM) buffer or in buffer with PLys:ATP coacervates (final coacervate concentration 40:10 mM). Final concentrations of reactants were 0.45 mM (β-NAD + ), 5 mM (sodium formate) and 0.002 un ml -1 (formate dehydrogenase). The reaction was initiated by the addition of the enzyme, mixed, and then loaded (20 uL) into a 384 well plate (microplate,693 PS, Small Volume, LoBase, Med. binding, Black, Greiner Bio-one). The kinetics of the reactions were recorded using TECAN Spark 20M well plate reader spectrophotometer (Tecan AG, Männedorf, Switzerland) by measuring the increase in NADH fluorescence over time (λ ex = 340 nm and λ em = 460 nm,5 nm bandwidth at 25 • C).
Activity of formate dehydrogenase in GUVs
Following the protocol outlined above, the inner lipid vesicles solution was prepared with formate dehydrogenase, sodium formate and β-NAD + , to final concentrations of 0.005 un ml -1 , 5 mM and 0.45 μm respectively, with and without coacervates. GUVs then underwent the same pH triggering methodology via washing as described and microscopy images were obtained immediately before pH switching and 24 hrs later.
Optical imaging of GUVs
Fluorescence confocal microscopy of GUVs was undertaken using a Zeiss LSM 880 Airy inverted laser scanning confocal microscope equipped with a Zeiss 40x/1.2 C-Apochromat DIC water immersion objective, a Zeiss 20x/0.8 Plan-Apochromat air objective and a 32 GaAsP PMT channel spectral detector. FITC labelled coacervates were imaged (λ FITC = 488 nm) by the 488 nm laser and emission wavelengths detected at λ FITC = 495 -579 nm . The DiD labelled lipid membranes (λ DID = 644 nm) were excited with a 633 nm laser for excitation and emission wavelengths detected at λ DiD = 652-695 nm. NADH, the product of the formate dehydrogenase reaction (λ NADH = 340 nm), was excited using a 355 nm DPPS UV laser and emission wavelengths detected at λ NADH = 420 -500 nm. Characterisation of GUVs and coacervate sizes was carried out with images obtained using the 40x lens. Fiji was used to obtain the fluorescence intensity across the GUVs using the line plot function for the DiD channels and the FITC channels. The fluorescence intensity of each of the channels was normalized to one. The images were further processed using a custom-made Fiji (Image J) macro that segmented GUV membranes and the coacervates inside them. The optical images were then further processed using MATLAB (Mathworks) to determine size of the vesicles or the coacervates. The correlated size distributions were fit to a liner regression model to calculate the R 2 values using MATLAB. The diameters were normalized by the mean to obtain the relative diameter.
Fluorescence recovery after photo bleaching
Fluorescence recovery after photobleaching (FRAP) experiments were undertaken for PLys/ATP coacervates microdroplets encapsulated in GUVs. All FRAP experiments were carried out using an Andor Eclipse Ti inverted spinning disk confocal microscope, equipped with a FRAPPA module and an Andor iXON 897 Monochrome EMCCD camera and imaged using a Nikon 60x/1.2 DIC Plan Apochromat VC water immersion objective. Bleaching of the droplet was achieved using a 405 nm diode laser at 100% power. Imaging was carried out using a 488 nm DPSS laser for excitation of the FITC dye at λ FITC = 488 with an emission wavelength of λ FITC = 500-590 nm. Due to the fast recovery of the coacervates, a reduced frame size of 4 x 512 dexels was used so that a higher temporal resolution could be achieved. For each experiment, 20 pre-bleach images were acquired before bleaching. The fluorescence recovery was then recorded by imaging for 3 mins at 4 frames msec -1 in the FITC channel only.
A custom written FIJI script was used to extract raw fluorescence data which was then normalized against a background region, a reference droplet and by the total fluorescence of the whole bleached droplet [2] [3] [4] . Using a custom MATLAB script, recovery profiles were fit to a double exponential curve using Eq. 1 to obtain the time constants τ 1 and τ 2 .
(1)
where t 0 is the first time point after bleaching, A1 and A2 are exponential prefactors, t is the time and tbleach is the time of bleaching. The time constants were calculated from at least 16 bleaching events from at least two different samples. Fitted time constants were then converted to diffusion constants using Eq. 2 5 , where r is the radius of the bleach spot.
(2)
Microfluidics
Giant vesicles were produced using a microfluidic chip design with two consecutive cross-junctions in a flow-focusing configuration that generates w/o/w double emulsion droplets. This design was based on the work published by Petit et al 6 and fabricated in the Robinson Lab using standard lithography methodologies. Briefly, PDMS and curing agent (Sylgard 184, Dow Corning) were mixed in a 9:1 ratio, degassed for 30 min and poured on top of the silicon wafer to a height of 5 mm in a petri dish. The PDMS was further degassed for 10 min and cured in an oven at 90 o C for 3 hrs. After which the PDMS was left to cool to room temperature and peeled from the wafer. Inlets were generated by punching holes using 1 mm biopsy puncher (Kai Europe GmbH) and then bonded to glass slides which has been cleaned with ethanol and water. For successful bonding, both the glass coverslips and PDMS slices were treated with an air plasma at 0.6 bar for a period of one minute using plasma cleaner (PDC-002-CE, Harrick Plasma). Microfluidic chips were kept on a hot plate at 60°C for 2h to complete the bonding process before further use. All channels were 50 µm in height. The outer solution channels of the microfluidic chip were hydrophilized by oxidizing the channels by flushing with a 3:1 mix of 30 wt.% H2O2 and 37 wt.% HCl for 5 mins and then treating the channels with 5 vol.% PDADMAC and 2 vol.% poly(sodium 4-styrenesulfonate) for 2 mins each with water washes in between.
The microfluidic chips were loaded onto a Zeiss Aziovert 200M inverted widefield microscope equipped with a 16 channel CooLED pE-300-W and ANDOR ZYLA fast sCMOS camera and imaged using 10x air objective (10x/0.3 Plan-Neofluar, Air, Ph1, Zeiss). FITC was imaged using a 470nm broad spectrum LED for excitation through a GFP/Alexa 488/FITC filter set (excitation bandpass 449-489 nm, dichroic longpass 497nm, emission bandpass 502-549 nm). Texas Red DHPE in the lipid membrane was imaged using a 550nm broad spectrum LED for excitation through a ROX filter set (excitation bandpass 575±15 nm, beam splitter HC BS 596, emission bandpass 641±75). The three fluid phases were controlled using three Mitos pressure pumps (Dolomite, Royston, UK). Target pressures were 70-80-100 mbar for the inner-middle-outer solutions respectively. The inner solution and the outer solution have been described previously with the addition of 2% pluronic in the outer solution at pH 11, the middle solution was an oil phase comprised of EggPC lipids at a final concentration of 6.5 mM dissolved in 1-Octanol with 0.008 mM Texas Red DHPE. Lipids were prepared by drying the required volumes of stock solution of EggPC dissolved in chloroform (25mg/ml) and Texas RED DHPE dissolved in chloroform (1mM) in a glass test tube under nitrogen for 15 mins, then left under vacuum for 1 hour. Solutions were the dissolved in 1.5 mL of 1-octanol by sonicating at 37°C in a water bath for 1 hour. Solutions were stored at room temperature and used within 24 hours. The vesicles were collected into micro-centrifuge tubes after formation and then pipetted onto homemade capillary slides formed from a 22x22 mm BSA coated cover slips mounted onto a parafilm channel on a 22 x 75 mm microscope slide. 15 µL of the GUV dispersion were loaded into the chamber, imaged using fluorescence widefield microscopy as described previously. Coacervation was initiated by flushing at least 7 µL of pH 7 buffer into the channel as described previously. The capillary channel was sealed completely with Picodent Twinsil speed curing silicone and images were taken every 5 minutes for 15 hours. Image analysis was undertaken using FIJI and custom written code as described previously. 
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